TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

PJP

Invesco Dynamic Pharmaceuticals ETF

NYSE ARCAETF
$120.91
+1.92%today

No SEC filings for this security

Invesco Dynamic Pharmaceuticals ETF is a foreign or OTC-listed security (NYSE ARCA) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$79.66 – $120.91
79.6652-week120.91
Market cap
$491M
Volume
11.6K
1Y return
+52.76%
Beta
0.00

Price · 1Y

$120.91▲ +52.76%
over 1Y
L $79.15H $120.91

Recent news

market news →
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?Bullish
finance.yahoo.com· 2026-06-29
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?Bullish
finance.yahoo.com· 2026-06-15
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on BiotechBullish
nasdaq.com· 2026-06-05
US Customs processing $20.6B in importer tariff refunds: reportBullish
seekingalpha.com· 2026-05-27
What Are Wall Street Analysts' Target Price for Amgen Stock?Bullish
finance.yahoo.com· 2026-04-30
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?Bullish
finance.yahoo.com· 2026-04-29
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?Bullish
finance.yahoo.com· 2026-02-23
The top-performing pharma and biotech stocks as group sees resurgenceBullish
seekingalpha.com· 2026-02-13

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.